Exit
In order to receive credit for this activity, you must read the front matter, view the activity, achieve a passing of at least 75% on this post-survey, as well as complete the evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements. 

There is no fee to participate in this activity.

Question Title

* 1. HCPs: What are your credentials?

Question Title

* 2. What is your community of practice?

Question Title

* 3. In what type of patients should molnupiravir be considered as a COVID-19 treatment?

Question Title

* 4. The disadvantage of using MOL versus PAX or RDV for COVID-19 infections in the outpatient setting is:

Question Title

* 5. 67-year-old male w/ Grade 4 CKD outpatient with COVID-19 symptom onset ≤5 days, tests positive for SARS-CoV-2 by PCR. Which antiviral do you recommend?

EVALUATION FORM

Question Title

* 6. Please rate how well the activity:

  Strongly agree Agree Neutral Disagree Strongly disagree
Met the learning objectives
Met your educational needs
Reinforced and/or improved your current skills
Gave you tools and strategies to apply in practive
Improved your ability to treat or manage your patients

Question Title

* 7. *Please rate the following:

  Yes No 
Did the activity address strategies for overcoming barriers to optimal patient care?
Was the content presented evidence-based and clinically relevant? 
Was the material presented in an objective manner and free from commercial interest?*
*(Commercial bias is defined as promoting a specific proprietary business interest of a commercial entity, and/or not including a balanced view of therapeutic options)

Question Title

* 8. As a result of what I learned, I intend to make changes in my practice:

Question Title

* 9. What change(s) will you incorporate into your practice as a result of what you have learned in this activity?

Question Title

* 10. I certify that I have participated in the continuing education activity entitled, "Smarter in Minutes #5: Molnupiravir" and claim 0.5 AMA PRA Category 1 CreditTM.

Question Title

* 11. If you are claiming credit, please provide your contact information so we can send your certificate. Certificates will be provided within 4-6 weeks.

Please note that we will not forward or sell your contact information.

Thank you for participating in our activity and completing the necessary paperwork. Please allow 4-6 weeks to receive your certificate. For information about the certification of this program, please contact National Jewish Health at proed@njhealth.org.
 
 100% of survey complete.
( Privacy & Cookie Notice

T